Lewicki John A.

Avg. Two Year Performance

No purchase track record
64% Avg. Sale Return
28% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return7%10%16%33%64%
Sale Success Rate8 of 179 of 1711 of 1711 of 1713 of 17
Drugs » Biotechnology

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Scientific Officer:

Holdings: 92.83K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--